Search

Author/Creator Markovic, Srdjan

1. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022)

Authors:
Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 1(2022)
Page Start:
17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Microsatellite instability affecting the T17 repeats in intron 8 of HSP110, as well as five mononucleotide repeats in patients with colorectal carcinoma. (August 2013)

Authors:
Markovic, Srdjan; Antic, Jadranka; Dimitrijevic, Ivan; Zogovic, Branimir; Bojic, Daniela; Svorcan, Petar; Markovic, Velimir; Krivokapic, Zoran
Journal:
Biomarkers in medicine
Issue:
Volume 7:Number 4(2013)
Page Start:
613
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗